Form 4: Medicine Man Technologies Director Acquires Shares for Board Service
SEC Form 4
Pratap Chandra Mukharji, a director of Medicine Man Technologies, acquired 67,308 shares of common stock as compensation for board service.
Summary
- Pratap Chandra Mukharji, a director at Medicine Man Technologies, acquired 67,308 shares of common stock on June 28, 2024.
- The shares were granted as compensation for his service on the board of directors.
- The aggregate value of the shares was $26,250, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
- Following the transaction, Mr. Mukharji directly owns 314,323 shares of common stock.
- He also indirectly owns 39,683 shares through Magnolia Hall Enterprises, LLC, where he is the manager and 100% owner.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director as part of their compensation. There are no inherently positive or negative implications.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the ownership of company stock by its directors.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of the transaction where Pratap Chandra Mukharji acquired shares of common stock. |
| 07/02/2024 | Date of signature for the Form 4 filing. |
Keywords
Medicine Man Technologies, SHWZ, Pratap Chandra Mukharji, Director, Stock Acquisition, Form 4, Beneficial Ownership, Magnolia Hall Enterprises, Board Service, Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.